St.Markus Koptisch-Orthodoxe Kirche Frankfurt e.V.
others
Location:
Frankfurt am Main,
Germany (DE)
ISNI: -
Long-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto) (2017)
Untch M, Schneeweiss A, Salat C, Rezai M, Zahm DM, Klare P, Blohmer JU, et al.
Conference contribution
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer (2012)
Wenners AS, Mehta K, Loibl S, Park H, Mueller B, Arnold N, Hamann S, et al.
Journal article